Deregulation of calcium homeostasis mediates secreted α-synuclein-induced neurotoxicity - PubMed (original) (raw)
Deregulation of calcium homeostasis mediates secreted α-synuclein-induced neurotoxicity
Katerina Melachroinou et al. Neurobiol Aging. 2013 Dec.
Abstract
α-Synuclein (AS) plays a crucial role in Parkinson's disease pathogenesis. AS is normally secreted from neuronal cells and can thus exert paracrine effects. We have previously demonstrated that naturally secreted AS species, derived from SH-SY5Y cells inducibly overexpressing human wild type AS, can be toxic to recipient neuronal cells. In the current study, we show that application of secreted AS alters membrane fluidity and increases calcium (Ca2+) entry. This influx is reduced on pharmacological inhibition of voltage-operated Ca2+ channels. Although no change in free cytosolic Ca2+ levels is observed, a significantly increased mitochondrial Ca2+ sequestration is found in recipient cells. Application of voltage-operated Ca2+ channel blockers or Ca2+ chelators abolishes AS-mediated toxicity. AS-treated cells exhibit increased calpain activation, and calpain inhibition greatly alleviates the observed toxicity. Collectively, our data suggest that secreted AS exerts toxicity through engagement, at least in part, of the Ca2+ homeostatic machinery. Therefore, manipulating Ca2+ signaling pathways might represent a potential therapeutic strategy for Parkinson's disease.
Keywords: Alpha-synuclein; Calpains; Exosomes; Membrane fluidity; Mitochondria; Neurodegeneration; Parkinson's disease; Secretion.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
- Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells.
Furukawa K, Matsuzaki-Kobayashi M, Hasegawa T, Kikuchi A, Sugeno N, Itoyama Y, Wang Y, Yao PJ, Bushlin I, Takeda A. Furukawa K, et al. J Neurochem. 2006 May;97(4):1071-7. doi: 10.1111/j.1471-4159.2006.03803.x. Epub 2006 Apr 5. J Neurochem. 2006. PMID: 16606366 - alpha-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells.
Hettiarachchi NT, Parker A, Dallas ML, Pennington K, Hung CC, Pearson HA, Boyle JP, Robinson P, Peers C. Hettiarachchi NT, et al. J Neurochem. 2009 Dec;111(5):1192-201. doi: 10.1111/j.1471-4159.2009.06411.x. Epub 2009 Oct 5. J Neurochem. 2009. PMID: 19860837 - Alpha-synuclein potentiates Ca2+ influx through voltage-dependent Ca2+ channels.
Adamczyk A, Strosznajder JB. Adamczyk A, et al. Neuroreport. 2006 Dec 18;17(18):1883-6. doi: 10.1097/WNR.0b013e3280115185. Neuroreport. 2006. PMID: 17179863 - Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies.
Vekrellis K, Stefanis L. Vekrellis K, et al. Expert Opin Ther Targets. 2012 Apr;16(4):421-32. doi: 10.1517/14728222.2012.674111. Expert Opin Ther Targets. 2012. PMID: 22480256 Review. - Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
Olanow CW, Brundin P. Olanow CW, et al. Mov Disord. 2013 Jan;28(1):31-40. doi: 10.1002/mds.25373. Mov Disord. 2013. PMID: 23390095 Review.
Cited by
- Determinants of dopaminergic neuron loss in Parkinson's disease.
Surmeier DJ. Surmeier DJ. FEBS J. 2018 Oct;285(19):3657-3668. doi: 10.1111/febs.14607. Epub 2018 Aug 14. FEBS J. 2018. PMID: 30028088 Free PMC article. Review. - Protein transmission in neurodegenerative disease.
Peng C, Trojanowski JQ, Lee VM. Peng C, et al. Nat Rev Neurol. 2020 Apr;16(4):199-212. doi: 10.1038/s41582-020-0333-7. Epub 2020 Mar 23. Nat Rev Neurol. 2020. PMID: 32203399 Free PMC article. Review. - Exogenous α-synuclein decreases raft partitioning of Cav2.2 channels inducing dopamine release.
Ronzitti G, Bucci G, Emanuele M, Leo D, Sotnikova TD, Mus LV, Soubrane CH, Dallas ML, Thalhammer A, Cingolani LA, Mochida S, Gainetdinov RR, Stephens GJ, Chieregatti E. Ronzitti G, et al. J Neurosci. 2014 Aug 6;34(32):10603-15. doi: 10.1523/JNEUROSCI.0608-14.2014. J Neurosci. 2014. PMID: 25100594 Free PMC article. - The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans.
Bornhorst J, Chakraborty S, Meyer S, Lohren H, Brinkhaus SG, Knight AL, Caldwell KA, Caldwell GA, Karst U, Schwerdtle T, Bowman A, Aschner M. Bornhorst J, et al. Metallomics. 2014 Mar;6(3):476-90. doi: 10.1039/c3mt00325f. Epub 2014 Jan 22. Metallomics. 2014. PMID: 24452053 Free PMC article. - The centrality of mitochondria in the pathogenesis and treatment of Parkinson's disease.
Camilleri A, Vassallo N. Camilleri A, et al. CNS Neurosci Ther. 2014 Jul;20(7):591-602. doi: 10.1111/cns.12264. Epub 2014 Apr 7. CNS Neurosci Ther. 2014. PMID: 24703487 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous